CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Seegene Inc Company Snapshot
Seegene Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seegene Inc with three other pharmaceutical manufacturers in Asia: Beijing Leadman Biochemistry Co Ltd of China (2017 sales of 575.98 million Chinese Renmimbi [US$83.14 million] of which 100% was Biological products industry), Guangdong Hybribio Biotech Co Ltd of China (479.09 million Chinese Renmimbi [US$69.15 million] of which 97% was Monitoring Instrument), and Getein Biotech Inc which is also based in China (488.58 million Chinese Renmimbi [US$70.52 million] of which 99% was In-vitro diagnostics).

Sales Analysis. Seegene Inc reported sales of 87.66 billion Korean Won (US$77.67 million) for the year ending December of 2017. This represents an increase of 19.0% versus 2016, when the company's sales were 73.69 billion Korean Won. Sales at Seegene Inc have increased during each of the previous five years (and since 2012, sales have increased a total of 70%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Seegene Inc
  Stock Performance Chart for Seegene Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/19/2018): 20,300
(Figures in Korean Won)
1 Week -0.7%   13 Weeks -15.1%  
4 Weeks -26.8%   52 Weeks -25.5%  
 
Seegene Inc Key Data:
  Ticker: 096530 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 87,662,544,746
(Year Ending Jan 2018).
Employees: 215
  Currency: Korean Won Market Cap: 527,637,072,200
  Fiscal Yr Ends: December Shares Outstanding: 25,991,974
  Share Type: Common Closely Held Shares: 8,747,394
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.